Measuring spleen stiffness in veterans with fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a new way to measure spleen stiffness in veterans with metabolic-dysfunction fatty liver disease. It may help doctors better understand and monitor this condition without invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand and agree to join this study
- You can read and understand English
- You have fatty liver disease confirmed by a past biopsy, scan, or doctor's note
- You are not pregnant
- You do not have severe liver damage (decompensated cirrhosis) or liver cancer
- You have your spleen
- You do not have a history of alcohol use disorder or drink more than 2 drinks a day (for women) or 3 drinks a day (for men)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
This study tests a new ultrasound method that measures spleen stiffness to help diagnose swollen veins in the esophagus (called esophageal varices) in people with chronic liver disease. If these veins are found early, it could help prevent dangerous bleeding.
This study uses an ultrasound probe during a routine endoscopy to measure liver stiffness, which can help detect liver scarring (fibrosis) in people with fatty liver disease (MASLD). If you are already scheduled for an endoscopy and have no signs of advanced liver scarring, you may be able to join.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
This study tests whether a new scoring method can help doctors identify liver inflammation in patients who have both type 2 diabetes and a fatty liver. The goal is to find an easier, safer way to assess liver health without invasive procedures.
This study follows people with a type of fatty liver disease called MAFLD to see if a reliable, painless ultrasound test called iLivTouch can help predict future liver problems. This could help doctors know who needs closer monitoring.
Hear when a new Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.